Skip to main content

Table 1 Maternal baseline characteristics, pregnancy outcome and neonatal data

From: Cognitive function in metformin exposed children, born to mothers with PCOS – follow-up of an RCT

 

Metformin (n = 52)

Placebo (n = 41)

p-value

Baseline data of the mothers in 1st trimester

Mean (SD)

Mean (SD)

 

 Age (years)

29.3 (3.4)

29.0 (4.3)

.762

 Weight (kg)

84.7 (19.4)

79.5 (19.2)

.215

 BMIa (kg/m2)

30.2 (7.0)

27.9 (6.3)

.105

 BPb systolic

121 (14)

117 (10)

.157

 BP diastolic

75 (10)

74 (7)

.569

Phenotype PCOSc:

n (%)

n (%)

.397

 A

26 (59)

21 (62)

 

 B

1 (2)

0

 

 C

5 (11)

1 (3)

 

 D

12 (27)

12 (35)

 

 Smoking

4 (8)

1 (3)

.279

Pregnancy outcome

 Gestational diabetes

12 (24)

11 (28)

.614

 Preeclampsia

4 (8)

2 (5)

.609

 Pre-term delivery

1 (2)

4 (10)

.089

 

Mean (SD)

Mean (SD)

 

Breastfeeding (months)

8.5 (4.5)

8.3 (3.8)

.864

Adherence to study medicationd

n (%)

n (%)

.724

 Good

42 (82)

30 (77)

 

 Acceptable

3 (6)

4 (10)

 

 Poor

6 (12)

5 (13)

 

Neonatal data

 Gender male/female

22/28

17/23

.887

 Apgar< 7 at 5 min

0

1 (3)

.252

 

Mean (SD)

Mean (SD)

 

 Weight (g)

3475 (482)

3582 (793)

.491

 Weight z-score

−0.28 (1.1)

0.07 (0.9)

.133

 Length (cm)

49.8 (2.1)

49.7 (3.4)

.933

 Length z-score

−0.71 (1.3)

− 0.49 (1.2)

.425

 Head circumference (cm)

35.7 (1.2)

34.7 (1.8)

.009

 Head circumference z-score

0.50 (1.0)

−0.02 (1.0)

.022

 Gestational age (weeks)

39.1 (1.3)

38.7 (2.7)

.508

  1. a BMI body mass index, b BP blood pressure, c A: hyperandrogenism (HA) + oligoamenorrhea (OA) + polycystic ovaries (PCO), B: HA + OA, C: HA + PCO, D: OA + PCO. d good compliance: medication taken as intended; acceptable compliance: reduced medication to one to two tablets per day for a maximum of 4 weeks and/or no tablets for a maximum 2 weeks, otherwise as intended; poor compliance: reduced medication to one to two tablets per day more than 4 weeks and/or no tablets more than 2 weeks